APO Research
Talk to an analyst

APO RESEARCH · REPORT

Calming Aids for Dogs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Calming Aids for Dogs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025194 pages

Choose your research edition.

Industry ResearchCalming Aids for Dogs Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Calming Aids for Dogs Industry Growth and Trends Forecast to 2032128 pages · $3,450 USDMarket StructureGlobal Calming Aids for Dogs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Calming Aids for Dogs Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Calming Aids for Dogs Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Calming Aids for Dogs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Calming Aids for Dogs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Calming Aids for Dogs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Calming Aids for Dogs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Calming Aids for Dogs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Calming Aids for Dogs include Zoetis, Shangrao Chunyu Technology, Shandong Youmi Le Health Technology, Zatural, Wild One, Vetoquinol, ThunderEase, This Dog's Life and The Anxious Pet, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Calming Aids for Dogs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Calming Aids for Dogs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Calming Aids for Dogs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Calming Aids for Dogs market size, projected growth trends, production technologies, key applications, and end-use industries.

Calming Aids for Dogs Segment by Company

Zoetis

Shangrao Chunyu Technology

Shandong Youmi Le Health Technology

Zatural

Wild One

Vetoquinol

ThunderEase

This Dog's Life

The Anxious Pet

Purina

Primo Pup

PetHonesty

Pet Remedy

Penelope's Bloom

NaturVet

Merck Animal Health

Maxxidog

Kradle

Koi CBD

King Kanine

Heavenly Hounds

FOMO Bones

Extract Labs

ElleVet Sciences

Elanco

Dr. Harvey’s

Ceva

Boehringer Ingelheim

Ark Naturals

Adaptil

Calming Aids for Dogs Segment by Type

Calming Collars

Calming Supplements

Pheromone Sprays

Anxiety Vests

Calming Aids for Dogs Segment by Application

Pet Shop

Pet Hospitals and Clinics

Household

Others

Calming Aids for Dogs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Calming Aids for Dogs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Calming Aids for Dogs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Calming Aids for Dogs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Calming Aids for Dogs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Calming Aids for Dogs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Calming Aids for Dogs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Calming Aids for Dogs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Calming Aids for Dogs Industry Trends Table 2. Calming Aids for Dogs Industry Drivers Table 3. Calming Aids for Dogs Industry Opportunities and Challenges Table 4. Calming Aids for Dogs Industry Restraints Table 5. Global Calming Aids for Dogs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Calming Aids for Dogs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Calming Aids for Dogs Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Calming Aids for Dogs Sales Market Share by Manufacturers Table 9. Global Calming Aids for Dogs Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Calming Aids for Dogs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Calming Aids for Dogs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Calming Aids for Dogs Manufacturers, Product Type & Application Table 13. Global Calming Aids for Dogs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Calming Aids for Dogs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Calming Collars Table 17. Major Manufacturers of Calming Supplements Table 18. Major Manufacturers of Pheromone Sprays Table 19. Major Manufacturers of Anxiety Vests Table 20. Global Calming Aids for Dogs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Calming Aids for Dogs Sales by Type (2021-2026) & (k units) Table 22. Global Calming Aids for Dogs Sales by Type (2027-2032) & (k units) Table 23. Global Calming Aids for Dogs Sales Market Share by Type (2021-2026) Table 24. Global Calming Aids for Dogs Sales Market Share by Type (2027-2032) Table 25. Global Calming Aids for Dogs Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Calming Aids for Dogs Revenue by Type (2021-2026) & (k units) Table 27. Global Calming Aids for Dogs Revenue by Type (2027-2032) & (k units) Table 28. Global Calming Aids for Dogs Revenue Market Share by Type (2021-2026) Table 29. Global Calming Aids for Dogs Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Pet Shop Table 31. Major Manufacturers of Pet Hospitals and Clinics Table 32. Major Manufacturers of Household Table 33. Major Manufacturers of Others Table 34. Global Calming Aids for Dogs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Calming Aids for Dogs Sales by Application (2021-2026) & (k units) Table 36. Global Calming Aids for Dogs Sales by Application (2027-2032) & (k units) Table 37. Global Calming Aids for Dogs Sales Market Share by Application (2021-2026) Table 38. Global Calming Aids for Dogs Sales Market Share by Application (2027-2032) Table 39. Global Calming Aids for Dogs Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 40. Global Calming Aids for Dogs Revenue by Application (2021-2026) & (k units) Table 41. Global Calming Aids for Dogs Revenue by Application (2027-2032) & (k units) Table 42. Global Calming Aids for Dogs Revenue Market Share by Application (2021-2026) Table 43. Global Calming Aids for Dogs Revenue Market Share by Application (2027-2032) Table 44. Global Calming Aids for Dogs Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Calming Aids for Dogs Sales by Region (2021-2026) & (k units) Table 46. Global Calming Aids for Dogs Sales Market Share by Region (2021-2026) Table 47. Global Calming Aids for Dogs Sales Forecasted by Region (2027-2032) & (k units) Table 48. Global Calming Aids for Dogs Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Calming Aids for Dogs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. North America Calming Aids for Dogs Sales by Country (2021-2026) & (k units) Table 51. North America Calming Aids for Dogs Sales by Country (2027-2032) & (k units) Table 52. Europe Calming Aids for Dogs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Europe Calming Aids for Dogs Sales by Country (2021-2026) & (k units) Table 54. Europe Calming Aids for Dogs Sales by Country (2027-2032) & (k units) Table 55. Asia Pacific Calming Aids for Dogs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Asia Pacific Calming Aids for Dogs Sales by Country (2021-2026) & (k units) Table 57. Asia Pacific Calming Aids for Dogs Sales by Country (2027-2032) & (k units) Table 58. South America, Middle East and Africa Calming Aids for Dogs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 59. South America, Middle East and Africa Calming Aids for Dogs Sales by Country (2021-2026) & (k units) Table 60. South America, Middle East and Africa Calming Aids for Dogs Sales by Country (2027-2032) & (k units) Table 61. Global Calming Aids for Dogs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Calming Aids for Dogs Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Calming Aids for Dogs Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Calming Aids for Dogs Revenue Market Share by Region (2021-2026) Table 65. Global Calming Aids for Dogs Revenue Market Share by Region (2027-2032) Table 66. Zoetis Company Information Table 67. Zoetis Business Overview Table 68. Zoetis Calming Aids for Dogs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Zoetis Calming Aids for Dogs Product Portfolio Table 70. Zoetis Recent Development Table 71. Shangrao Chunyu Technology Company Information Table 72. Shangrao Chunyu Technology Business Overview Table 73. Shangrao Chunyu Technology Calming Aids for Dogs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Shangrao Chunyu Technology Calming Aids for Dogs Product Portfolio Table 75. Shangrao Chunyu Technology Recent Development Table 76. Shandong Youmi Le Health Technology Company Information Table 77. Shandong Youmi Le Health Technology Business Overview Table 78. Shandong Youmi Le Health Technology Calming Aids for Dogs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Shandong Youmi Le Health Technology Calming Aids for Dogs Product Portfolio Table 80. Shandong Youmi Le Health Technology Recent Development Table 81. Zatural Company Information Table 82. Zatural Business Overview Table 83. Zatural Calming Aids for Dogs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Zatural Calming Aids for Dogs Product Portfolio Table 85. Zatural Recent Development Table 86. Wild One Company Information Table 87. Wild One Business Overview Table 88. Wild One Calming Aids for Dogs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Wild One Calming Aids for Dogs Product Portfolio Table 90. Wild One Recent Development Table 91. Vetoquinol Company Information Table 92. Vetoquinol Business Overview Table 93. Vetoquinol Calming Aids for Dogs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Vetoquinol Calming Aids for Dogs Product Portfolio Table 95. Vetoquinol Recent Development Table 96. ThunderEase Company Information Table 97. ThunderEase Business Overview Table 98. ThunderEase Calming Aids for Dogs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. ThunderEase Calming Aids for Dogs Product Portfolio Table 100. ThunderEase Recent Development Table 101. This Dog's Life Company Information Table 102. This Dog's Life Business Overview Table 103. This Dog's Life Calming Aids for Dogs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. This Dog's Life Calming Aids for Dogs Product Portfolio Table 105. This Dog's Life Recent Development Table 106. The Anxious Pet Company Information Table 107. The Anxious Pet Business Overview Table 108. The Anxious Pet Calming Aids for Dogs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. The Anxious Pet Calming Aids for Dogs Product Portfolio Table 110. The Anxious Pet Recent Development Table 111. Purina Company Information Table 112. Purina Business Overview Table 113. Purina Calming Aids for Dogs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Purina Calming Aids for Dogs Product Portfolio Table 115. Purina Recent Development Table 116. Primo Pup Company Information Table 117. Primo Pup Business Overview Table 118. Primo Pup Calming Aids for Dogs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Primo Pup Calming Aids for Dogs Product Portfolio Table 120. Primo Pup Recent Development Table 121. PetHonesty Company Information Table 122. PetHonesty Business Overview Table 123. PetHonesty Calming Aids for Dogs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. PetHonesty Calming Aids for Dogs Product Portfolio Table 125. PetHonesty Recent Development Table 126. Pet Remedy Company Information Table 127. Pet Remedy Business Overview Table 128. Pet Remedy Calming Aids for Dogs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Pet Remedy Calming Aids for Dogs Product Portfolio Table 130. Pet Remedy Recent Development Table 131. Penelope's Bloom Company Information Table 132. Penelope's Bloom Business Overview Table 133. Penelope's Bloom Calming Aids for Dogs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Penelope's Bloom Calming Aids for Dogs Product Portfolio Table 135. Penelope's Bloom Recent Development Table 136. NaturVet Company Information Table 137. NaturVet Business Overview Table 138. NaturVet Calming Aids for Dogs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. NaturVet Calming Aids for Dogs Product Portfolio Table 140. NaturVet Recent Development Table 141. Merck Animal Health Company Information Table 142. Merck Animal Health Business Overview Table 143. Merck Animal Health Calming Aids for Dogs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 144. Merck Animal Health Calming Aids for Dogs Product Portfolio Table 145. Merck Animal Health Recent Development Table 146. Maxxidog Company Information Table 147. Maxxidog Business Overview Table 148. Maxxidog Calming Aids for Dogs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 149. Maxxidog Calming Aids for Dogs Product Portfolio Table 150. Maxxidog Recent Development Table 151. Kradle Company Information Table 152. Kradle Business Overview Table 153. Kradle Calming Aids for Dogs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 154. Kradle Calming Aids for Dogs Product Portfolio Table 155. Kradle Recent Development Table 156. Koi CBD Company Information Table 157. Koi CBD Business Overview Table 158. Koi CBD Calming Aids for Dogs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 159. Koi CBD Calming Aids for Dogs Product Portfolio Table 160. Koi CBD Recent Development Table 161. King Kanine Company Information Table 162. King Kanine Business Overview Table 163. King Kanine Calming Aids for Dogs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 164. King Kanine Calming Aids for Dogs Product Portfolio Table 165. King Kanine Recent Development Table 166. Heavenly Hounds Company Information Table 167. Heavenly Hounds Business Overview Table 168. Heavenly Hounds Calming Aids for Dogs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 169. Heavenly Hounds Calming Aids for Dogs Product Portfolio Table 170. Heavenly Hounds Recent Development Table 171. FOMO Bones Company Information Table 172. FOMO Bones Business Overview Table 173. FOMO Bones Calming Aids for Dogs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 174. FOMO Bones Calming Aids for Dogs Product Portfolio Table 175. FOMO Bones Recent Development Table 176. Extract Labs Company Information Table 177. Extract Labs Business Overview Table 178. Extract Labs Calming Aids for Dogs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 179. Extract Labs Calming Aids for Dogs Product Portfolio Table 180. Extract Labs Recent Development Table 181. ElleVet Sciences Company Information Table 182. ElleVet Sciences Business Overview Table 183. ElleVet Sciences Calming Aids for Dogs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 184. ElleVet Sciences Calming Aids for Dogs Product Portfolio Table 185. ElleVet Sciences Recent Development Table 186. Elanco Company Information Table 187. Elanco Business Overview Table 188. Elanco Calming Aids for Dogs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 189. Elanco Calming Aids for Dogs Product Portfolio Table 190. Elanco Recent Development Table 191. Dr. Harvey’s Company Information Table 192. Dr. Harvey’s Business Overview Table 193. Dr. Harvey’s Calming Aids for Dogs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 194. Dr. Harvey’s Calming Aids for Dogs Product Portfolio Table 195. Dr. Harvey’s Recent Development Table 196. Ceva Company Information Table 197. Ceva Business Overview Table 198. Ceva Calming Aids for Dogs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 199. Ceva Calming Aids for Dogs Product Portfolio Table 200. Ceva Recent Development Table 201. Boehringer Ingelheim Company Information Table 202. Boehringer Ingelheim Business Overview Table 203. Boehringer Ingelheim Calming Aids for Dogs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 204. Boehringer Ingelheim Calming Aids for Dogs Product Portfolio Table 205. Boehringer Ingelheim Recent Development Table 206. Ark Naturals Company Information Table 207. Ark Naturals Business Overview Table 208. Ark Naturals Calming Aids for Dogs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 209. Ark Naturals Calming Aids for Dogs Product Portfolio Table 210. Ark Naturals Recent Development Table 211. Adaptil Company Information Table 212. Adaptil Business Overview Table 213. Adaptil Calming Aids for Dogs Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 214. Adaptil Calming Aids for Dogs Product Portfolio Table 215. Adaptil Recent Development Table 216. Key Raw Materials Table 217. Raw Materials Key Suppliers Table 218. Calming Aids for Dogs Distributors List Table 219. Calming Aids for Dogs Customers List Table 220. Research Programs/Design for This Report Table 221. Authors List of This Report Table 222. Secondary Sources Table 223. Primary Sources List of Figures Figure 1. Calming Aids for Dogs Product Image Figure 2. Global Calming Aids for Dogs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Calming Aids for Dogs Market Size (2021-2032) & (US$ Million) Figure 4. Global Calming Aids for Dogs Sales (2021-2032) & (k units) Figure 5. Global Calming Aids for Dogs Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Calming Aids for Dogs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Calming Collars Image Figure 9. Calming Supplements Image Figure 10. Pheromone Sprays Image Figure 11. Anxiety Vests Image Figure 12. Global Calming Aids for Dogs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Calming Aids for Dogs Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Calming Aids for Dogs Sales Market Share by Type (2021-2032) Figure 15. Global Calming Aids for Dogs Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Calming Aids for Dogs Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Calming Aids for Dogs Revenue Market Share by Type (2021-2032) Figure 18. Pet Shop Image Figure 19. Pet Hospitals and Clinics Image Figure 20. Household Image Figure 21. Others Image Figure 22. Global Calming Aids for Dogs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Calming Aids for Dogs Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Calming Aids for Dogs Sales Market Share by Application (2021-2032) Figure 25. Global Calming Aids for Dogs Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global Calming Aids for Dogs Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Calming Aids for Dogs Revenue Market Share by Application (2021-2032) Figure 28. North America Calming Aids for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 29. North America Calming Aids for Dogs Sales Market Share by Country (2021-2032) Figure 30. U.S. Calming Aids for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 31. Canada Calming Aids for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 32. Mexico Calming Aids for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Calming Aids for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Calming Aids for Dogs Sales Market Share by Country (2021-2032) Figure 35. Germany Calming Aids for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 36. France Calming Aids for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 37. U.K. Calming Aids for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 38. Italy Calming Aids for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 39. Netherlands Calming Aids for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Calming Aids for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Calming Aids for Dogs Sales Market Share by Country (2021-2032) Figure 42. China Calming Aids for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 43. Japan Calming Aids for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 44. South Korea Calming Aids for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 45. Southeast Asia Calming Aids for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 46. India Calming Aids for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 47. Australia Calming Aids for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Calming Aids for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Calming Aids for Dogs Sales Market Share by Country (2021-2032) Figure 50. Brazil Calming Aids for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 51. South Africa Calming Aids for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 52. Saudi Arabia Calming Aids for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 53. Turkey Calming Aids for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 54. Argentina Calming Aids for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 55. UAE Calming Aids for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 56. Egypt Calming Aids for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 57. Chile Calming Aids for Dogs Sales and Growth Rate (2021-2032) & (k units) Figure 58. Global Calming Aids for Dogs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Calming Aids for Dogs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Calming Aids for Dogs Revenue (2021-2032) & (US$ Million) Figure 61. North America Calming Aids for Dogs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Calming Aids for Dogs Revenue (2021-2032) & (US$ Million) Figure 63. Europe Calming Aids for Dogs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Calming Aids for Dogs Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Calming Aids for Dogs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Calming Aids for Dogs Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Calming Aids for Dogs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Calming Aids for Dogs Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Calming Aids for Dogs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Calming Collars
  • Calming Supplements
  • Pheromone Sprays
  • Anxiety Vests
Applications
  • Pet Shop
  • Pet Hospitals and Clinics
  • Household
  • Others
Companies covered
  • Zoetis
  • Shangrao Chunyu Technology
  • Shandong Youmi Le Health Technology
  • Zatural
  • Wild One
  • Vetoquinol
  • ThunderEase
  • This Dog's Life
  • The Anxious Pet
  • Purina
  • Primo Pup
  • PetHonesty
  • Pet Remedy
  • Penelope's Bloom
  • NaturVet
  • Merck Animal Health
  • Maxxidog
  • Kradle
  • Koi CBD
  • King Kanine
  • Heavenly Hounds
  • FOMO Bones
  • Extract Labs
  • ElleVet Sciences
  • Elanco
  • Dr. Harvey’s
  • Ceva
  • Boehringer Ingelheim
  • Ark Naturals
  • Adaptil

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Calming Aids for Dogs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Calming Aids for Dogs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Calming Aids for Dogs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Calming Aids for Dogs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Calming Aids for Dogs Market Dynamics
  1. 2.1 Calming Aids for Dogs Industry Trends
  2. 2.2 Calming Aids for Dogs Industry Drivers
  3. 2.3 Calming Aids for Dogs Industry Opportunities and Challenges
  4. 2.4 Calming Aids for Dogs Industry Restraints
3 Calming Aids for Dogs Market by Manufacturers
  1. 3.1 Global Calming Aids for Dogs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Calming Aids for Dogs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Calming Aids for Dogs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Calming Aids for Dogs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Calming Aids for Dogs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Calming Aids for Dogs Manufacturers, Product Type & Application
  7. 3.7 Global Calming Aids for Dogs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Calming Aids for Dogs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Calming Aids for Dogs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Calming Aids for Dogs Tier 1, Tier 2, and Tier 3
4 Calming Aids for Dogs Market by Type
  1. 4.1 Calming Aids for Dogs Type Introduction
  2. 4.1.1 Calming Collars
  3. 4.1.2 Calming Supplements
  4. 4.1.3 Pheromone Sprays
  5. 4.1.4 Anxiety Vests
  6. 4.2 Global Calming Aids for Dogs Sales by Type
  7. 4.2.1 Global Calming Aids for Dogs Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Calming Aids for Dogs Sales by Type (2021-2032)
  9. 4.2.3 Global Calming Aids for Dogs Sales Market Share by Type (2021-2032)
  10. 4.3 Global Calming Aids for Dogs Revenue by Type
  11. 4.3.1 Global Calming Aids for Dogs Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Calming Aids for Dogs Revenue by Type (2021-2032)
  13. 4.3.3 Global Calming Aids for Dogs Revenue Market Share by Type (2021-2032)
5 Calming Aids for Dogs Market by Application
  1. 5.1 Calming Aids for Dogs Application Introduction
  2. 5.1.1 Pet Shop
  3. 5.1.2 Pet Hospitals and Clinics
  4. 5.1.3 Household
  5. 5.1.4 Others
  6. 5.2 Global Calming Aids for Dogs Sales by Application
  7. 5.2.1 Global Calming Aids for Dogs Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Calming Aids for Dogs Sales by Application (2021-2032)
  9. 5.2.3 Global Calming Aids for Dogs Sales Market Share by Application (2021-2032)
  10. 5.3 Global Calming Aids for Dogs Revenue by Application
  11. 5.3.1 Global Calming Aids for Dogs Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Calming Aids for Dogs Revenue by Application (2021-2032)
  13. 5.3.3 Global Calming Aids for Dogs Revenue Market Share by Application (2021-2032)
6 Global Calming Aids for Dogs Sales by Region
  1. 6.1 Global Calming Aids for Dogs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Calming Aids for Dogs Sales by Region (2021-2032)
  3. 6.2.1 Global Calming Aids for Dogs Sales by Region (2021-2026)
  4. 6.2.2 Global Calming Aids for Dogs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Calming Aids for Dogs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Calming Aids for Dogs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Calming Aids for Dogs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Calming Aids for Dogs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Calming Aids for Dogs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Calming Aids for Dogs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Calming Aids for Dogs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Calming Aids for Dogs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Calming Aids for Dogs Revenue by Region
  1. 7.1 Global Calming Aids for Dogs Revenue by Region
  2. 7.1.1 Global Calming Aids for Dogs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Calming Aids for Dogs Revenue by Region (2021-2026)
  4. 7.1.3 Global Calming Aids for Dogs Revenue by Region (2027-2032)
  5. 7.1.4 Global Calming Aids for Dogs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Calming Aids for Dogs Revenue (2021-2032)
  8. 7.2.2 North America Calming Aids for Dogs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Calming Aids for Dogs Revenue (2021-2032)
  11. 7.3.2 Europe Calming Aids for Dogs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Calming Aids for Dogs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Calming Aids for Dogs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Calming Aids for Dogs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Calming Aids for Dogs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis
  2. 8.1.1 Zoetis Company Information
  3. 8.1.2 Zoetis Business Overview
  4. 8.1.3 Zoetis Calming Aids for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Calming Aids for Dogs Product Portfolio
  6. 8.1.5 Zoetis Recent Developments
  7. 8.2 Shangrao Chunyu Technology
  8. 8.2.1 Shangrao Chunyu Technology Company Information
  9. 8.2.2 Shangrao Chunyu Technology Business Overview
  10. 8.2.3 Shangrao Chunyu Technology Calming Aids for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Shangrao Chunyu Technology Calming Aids for Dogs Product Portfolio
  12. 8.2.5 Shangrao Chunyu Technology Recent Developments
  13. 8.3 Shandong Youmi Le Health Technology
  14. 8.3.1 Shandong Youmi Le Health Technology Company Information
  15. 8.3.2 Shandong Youmi Le Health Technology Business Overview
  16. 8.3.3 Shandong Youmi Le Health Technology Calming Aids for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shandong Youmi Le Health Technology Calming Aids for Dogs Product Portfolio
  18. 8.3.5 Shandong Youmi Le Health Technology Recent Developments
  19. 8.4 Zatural
  20. 8.4.1 Zatural Company Information
  21. 8.4.2 Zatural Business Overview
  22. 8.4.3 Zatural Calming Aids for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Zatural Calming Aids for Dogs Product Portfolio
  24. 8.4.5 Zatural Recent Developments
  25. 8.5 Wild One
  26. 8.5.1 Wild One Company Information
  27. 8.5.2 Wild One Business Overview
  28. 8.5.3 Wild One Calming Aids for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Wild One Calming Aids for Dogs Product Portfolio
  30. 8.5.5 Wild One Recent Developments
  31. 8.6 Vetoquinol
  32. 8.6.1 Vetoquinol Company Information
  33. 8.6.2 Vetoquinol Business Overview
  34. 8.6.3 Vetoquinol Calming Aids for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Vetoquinol Calming Aids for Dogs Product Portfolio
  36. 8.6.5 Vetoquinol Recent Developments
  37. 8.7 ThunderEase
  38. 8.7.1 ThunderEase Company Information
  39. 8.7.2 ThunderEase Business Overview
  40. 8.7.3 ThunderEase Calming Aids for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 ThunderEase Calming Aids for Dogs Product Portfolio
  42. 8.7.5 ThunderEase Recent Developments
  43. 8.8 This Dog's Life
  44. 8.8.1 This Dog's Life Company Information
  45. 8.8.2 This Dog's Life Business Overview
  46. 8.8.3 This Dog's Life Calming Aids for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 This Dog's Life Calming Aids for Dogs Product Portfolio
  48. 8.8.5 This Dog's Life Recent Developments
  49. 8.9 The Anxious Pet
  50. 8.9.1 The Anxious Pet Company Information
  51. 8.9.2 The Anxious Pet Business Overview
  52. 8.9.3 The Anxious Pet Calming Aids for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 The Anxious Pet Calming Aids for Dogs Product Portfolio
  54. 8.9.5 The Anxious Pet Recent Developments
  55. 8.10 Purina
  56. 8.10.1 Purina Company Information
  57. 8.10.2 Purina Business Overview
  58. 8.10.3 Purina Calming Aids for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Purina Calming Aids for Dogs Product Portfolio
  60. 8.10.5 Purina Recent Developments
  61. 8.11 Primo Pup
  62. 8.11.1 Primo Pup Company Information
  63. 8.11.2 Primo Pup Business Overview
  64. 8.11.3 Primo Pup Calming Aids for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Primo Pup Calming Aids for Dogs Product Portfolio
  66. 8.11.5 Primo Pup Recent Developments
  67. 8.12 PetHonesty
  68. 8.12.1 PetHonesty Company Information
  69. 8.12.2 PetHonesty Business Overview
  70. 8.12.3 PetHonesty Calming Aids for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 PetHonesty Calming Aids for Dogs Product Portfolio
  72. 8.12.5 PetHonesty Recent Developments
  73. 8.13 Pet Remedy
  74. 8.13.1 Pet Remedy Company Information
  75. 8.13.2 Pet Remedy Business Overview
  76. 8.13.3 Pet Remedy Calming Aids for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Pet Remedy Calming Aids for Dogs Product Portfolio
  78. 8.13.5 Pet Remedy Recent Developments
  79. 8.14 Penelope's Bloom
  80. 8.14.1 Penelope's Bloom Company Information
  81. 8.14.2 Penelope's Bloom Business Overview
  82. 8.14.3 Penelope's Bloom Calming Aids for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Penelope's Bloom Calming Aids for Dogs Product Portfolio
  84. 8.14.5 Penelope's Bloom Recent Developments
  85. 8.15 NaturVet
  86. 8.15.1 NaturVet Company Information
  87. 8.15.2 NaturVet Business Overview
  88. 8.15.3 NaturVet Calming Aids for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 NaturVet Calming Aids for Dogs Product Portfolio
  90. 8.15.5 NaturVet Recent Developments
  91. 8.16 Merck Animal Health
  92. 8.16.1 Merck Animal Health Company Information
  93. 8.16.2 Merck Animal Health Business Overview
  94. 8.16.3 Merck Animal Health Calming Aids for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Merck Animal Health Calming Aids for Dogs Product Portfolio
  96. 8.16.5 Merck Animal Health Recent Developments
  97. 8.17 Maxxidog
  98. 8.17.1 Maxxidog Company Information
  99. 8.17.2 Maxxidog Business Overview
  100. 8.17.3 Maxxidog Calming Aids for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Maxxidog Calming Aids for Dogs Product Portfolio
  102. 8.17.5 Maxxidog Recent Developments
  103. 8.18 Kradle
  104. 8.18.1 Kradle Company Information
  105. 8.18.2 Kradle Business Overview
  106. 8.18.3 Kradle Calming Aids for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Kradle Calming Aids for Dogs Product Portfolio
  108. 8.18.5 Kradle Recent Developments
  109. 8.19 Koi CBD
  110. 8.19.1 Koi CBD Company Information
  111. 8.19.2 Koi CBD Business Overview
  112. 8.19.3 Koi CBD Calming Aids for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Koi CBD Calming Aids for Dogs Product Portfolio
  114. 8.19.5 Koi CBD Recent Developments
  115. 8.20 King Kanine
  116. 8.20.1 King Kanine Company Information
  117. 8.20.2 King Kanine Business Overview
  118. 8.20.3 King Kanine Calming Aids for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 King Kanine Calming Aids for Dogs Product Portfolio
  120. 8.20.5 King Kanine Recent Developments
  121. 8.21 Heavenly Hounds
  122. 8.21.1 Heavenly Hounds Company Information
  123. 8.21.2 Heavenly Hounds Business Overview
  124. 8.21.3 Heavenly Hounds Calming Aids for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Heavenly Hounds Calming Aids for Dogs Product Portfolio
  126. 8.21.5 Heavenly Hounds Recent Developments
  127. 8.22 FOMO Bones
  128. 8.22.1 FOMO Bones Company Information
  129. 8.22.2 FOMO Bones Business Overview
  130. 8.22.3 FOMO Bones Calming Aids for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 FOMO Bones Calming Aids for Dogs Product Portfolio
  132. 8.22.5 FOMO Bones Recent Developments
  133. 8.23 Extract Labs
  134. 8.23.1 Extract Labs Company Information
  135. 8.23.2 Extract Labs Business Overview
  136. 8.23.3 Extract Labs Calming Aids for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Extract Labs Calming Aids for Dogs Product Portfolio
  138. 8.23.5 Extract Labs Recent Developments
  139. 8.24 ElleVet Sciences
  140. 8.24.1 ElleVet Sciences Company Information
  141. 8.24.2 ElleVet Sciences Business Overview
  142. 8.24.3 ElleVet Sciences Calming Aids for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  143. 8.24.4 ElleVet Sciences Calming Aids for Dogs Product Portfolio
  144. 8.24.5 ElleVet Sciences Recent Developments
  145. 8.25 Elanco
  146. 8.25.1 Elanco Company Information
  147. 8.25.2 Elanco Business Overview
  148. 8.25.3 Elanco Calming Aids for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Elanco Calming Aids for Dogs Product Portfolio
  150. 8.25.5 Elanco Recent Developments
  151. 8.26 Dr. Harvey’s
  152. 8.26.1 Dr. Harvey’s Company Information
  153. 8.26.2 Dr. Harvey’s Business Overview
  154. 8.26.3 Dr. Harvey’s Calming Aids for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  155. 8.26.4 Dr. Harvey’s Calming Aids for Dogs Product Portfolio
  156. 8.26.5 Dr. Harvey’s Recent Developments
  157. 8.27 Ceva
  158. 8.27.1 Ceva Company Information
  159. 8.27.2 Ceva Business Overview
  160. 8.27.3 Ceva Calming Aids for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  161. 8.27.4 Ceva Calming Aids for Dogs Product Portfolio
  162. 8.27.5 Ceva Recent Developments
  163. 8.28 Boehringer Ingelheim
  164. 8.28.1 Boehringer Ingelheim Company Information
  165. 8.28.2 Boehringer Ingelheim Business Overview
  166. 8.28.3 Boehringer Ingelheim Calming Aids for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  167. 8.28.4 Boehringer Ingelheim Calming Aids for Dogs Product Portfolio
  168. 8.28.5 Boehringer Ingelheim Recent Developments
  169. 8.29 Ark Naturals
  170. 8.29.1 Ark Naturals Company Information
  171. 8.29.2 Ark Naturals Business Overview
  172. 8.29.3 Ark Naturals Calming Aids for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  173. 8.29.4 Ark Naturals Calming Aids for Dogs Product Portfolio
  174. 8.29.5 Ark Naturals Recent Developments
  175. 8.30 Adaptil
  176. 8.30.1 Adaptil Company Information
  177. 8.30.2 Adaptil Business Overview
  178. 8.30.3 Adaptil Calming Aids for Dogs Sales, Price, Revenue and Gross Margin (2021-2026)
  179. 8.30.4 Adaptil Calming Aids for Dogs Product Portfolio
  180. 8.30.5 Adaptil Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Calming Aids for Dogs Value Chain Analysis
  2. 9.1.1 Calming Aids for Dogs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Calming Aids for Dogs Production Mode & Process
  6. 9.2 Calming Aids for Dogs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Calming Aids for Dogs Distributors
  9. 9.2.3 Calming Aids for Dogs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst